GH Research PLC

GHRSNASDAQ · USD
24.45USD-1.51 (-5.82%)
2310

GH Research PLC (GHRS) Wheel Strategy

GHRS wheel strategy scan found 5 cash-secured put setups on the previous trading day. Probability of expiring worthless is above 50%. Annualized returns reach up to 57.0%.

Read more

Running a GHRS wheel strategy lets you generate consistent premium income on GH Research PLC while setting your own entry and exit prices on the underlying. GH Research PLC's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own GHRS, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best GHRS wheel strategy setups in real time.

The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on GHRS, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable GHRS wheel from a losing one.

GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH001, an inhalable 5-MeO-DMT product candidate that has completed two Phase 1 clinical trials and Phase 1/2 clinical trial in patients with TRD. The company also develops GH002, an injectable 5-MeO-DMT product candidate; and GH003, an intranasal 5-MeO-DMT product candidate, which are in preclinical development trials with a focus on psychiatric and neurological disorders.

GH Research PLC was incorporated in 2018 and is based in Dublin, Ireland.

The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the GHRS wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your GHRS wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.

Nov 20, 202625.00$0.10$2.50-0.29646%63.9%57.0%0
Jan 15, 202725.00$0.60$2.75-0.281206%57.2%33.5%5
Jan 15, 202722.50$0.10$1.75-0.211206%67.2%23.7%8
Apr 16, 202725.00$1.20$3.35-0.282116%51.7%23.2%2
Apr 16, 202722.50$0.50$2.70-0.222116%59.5%20.8%0

As of September 23, 2026

Run the Wheel on GHRS With Confidence

Find the best GHRS wheel strategy setups across strikes and expirations, plan ahead with at-strike values, and keep your covered calls and puts on track.

Start your 14-day free trial